{"id":54400,"date":"2025-01-10T14:24:17","date_gmt":"2025-01-10T14:24:17","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=54400"},"modified":"2025-01-10T14:24:17","modified_gmt":"2025-01-10T14:24:17","slug":"eu-health-technology-assessment-to-revolutionise-patient-care","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/eu-health-technology-assessment-to-revolutionise-patient-care\/54400\/","title":{"rendered":"EU Health Technology Assessment to revolutionise patient care"},"content":{"rendered":"

The European Union’s long-awaited Health Technology Assessment (HTA) Regulation comes into effect on 12 January, ushering in a new era of healthcare innovation across the EU.<\/h2>\n

On Sunday, the EU takes a pivotal step forward with the implementation of the Regulation on Health Technology Assessment (HTA).<\/p>\n

This groundbreaking framework aims to enhance the availability of innovative and effective health technologies<\/a>, ensuring patients across the EU benefit from timely access to life-changing treatments.<\/p>\n

Discussing the HTA, Oliv\u00e9r V\u00e1rhelyi, Commissioner for Health and Animal Welfare, noted: “I welcome the start of application of the new EU rules on Health Technology Assessment.<\/p>\n

“European patients need quicker access to innovative and lifesaving medicines and medical devices, and we are one step closer to making this a reality.<\/p>\n

“We must now ensure that these rules are fully put into practice across the EU \u2013 to make better use of available resources, to ensure faster entry into the market for pharmaceuticals with lower costs, less red tape and faster administrative procedures to get them included into the reimbursement schemes.<\/p>\n

“This is central for a strong European Health Union that delivers for citizens and strengthens the EU’s competitiveness.<\/p>\n

Health Technology Assessment explained<\/h3>\n

Health Technology Assessment is an evidence-based, scientific process that evaluates the medical, social, economic, and ethical dimensions of health technologies. Its purpose is to guide policymakers in crafting informed and safe healthcare strategies.<\/p>\n

The new regulation builds on a vision proposed by the European Commission in January 2018 and represents a significant achievement of the EU Pharmaceutical Strategy<\/a>.<\/p>\n

Following its adoption in December 2021, the regulation entered into force in January 2022 but allowed for a three-year transitional period to establish the necessary governance structures and prepare for seamless implementation.<\/p>\n

Key features of the regulation<\/h3>\n

The HTA establishes a unified framework for assessing health technologies, including medicines and medical devices, by promoting collaboration among EU Member States.<\/p>\n

This approach will streamline processes for developers, ensure higher scientific quality, and reduce redundancy in national assessments.<\/p>\n

The regulation includes several transformative elements:<\/p>\n